Emerging therapeutics for the management of COVID 19

Taylor and Francis Group, Expert Opinion on Emerging Drugs, 3(25), p. 337-351, 2020

Journal article published in 2020 by Sujit Kumar Debnath

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by